These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
288 related items for PubMed ID: 27473453
1. Clinical and immunologic features of recurrent herpes zoster (HZ). Nakamura Y, Miyagawa F, Okazaki A, Okuno Y, Mori Y, Iso H, Yamanishi K, Asada H, Shozu Herpes Zoster Study Group. J Am Acad Dermatol; 2016 Nov; 75(5):950-956.e1. PubMed ID: 27473453 [Abstract] [Full Text] [Related]
2. VZV skin-test reaction, but not antibody, is an important predictive factor for postherpetic neuralgia. Imoto K, Okazaki A, Onishi F, Miyazaki Y, Okeda M, Yano S, Takao Y, Gomi Y, Ishikawa T, Okuno Y, Mori Y, Iso H, Yamanishi K, Asada H, SHEZ study group. J Dermatol Sci; 2015 Sep; 79(3):235-40. PubMed ID: 26070505 [Abstract] [Full Text] [Related]
3. An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain. Asada H, Nagayama K, Okazaki A, Mori Y, Okuno Y, Takao Y, Miyazaki Y, Onishi F, Okeda M, Yano S, Kumihashi H, Gomi Y, Maeda K, Ishikawa T, Iso H, Yamanishi K, Shozu Herpes Zoster (SHEZ) Study group. J Dermatol Sci; 2013 Mar; 69(3):243-9. PubMed ID: 23183011 [Abstract] [Full Text] [Related]
5. Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study. Takao Y, Miyazaki Y, Okeda M, Onishi F, Yano S, Gomi Y, Ishikawa T, Okuno Y, Mori Y, Asada H, Yamanishi K, Iso H. J Epidemiol; 2015 Mar; 25(10):617-25. PubMed ID: 26399445 [Abstract] [Full Text] [Related]
6. Vaccination: a new option to reduce the burden of herpes zoster. Mick G. Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716 [Abstract] [Full Text] [Related]
7. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study. Schmidt-Ott R, Schutter U, Simon J, Nautrup BP, von Krempelhuber A, Gopala K, Anastassopoulou A, Guignard A, Curran D, Matthews S, Espié E. J Infect; 2018 May; 76(5):475-482. PubMed ID: 29428228 [Abstract] [Full Text] [Related]
9. The Shozu Herpes Zoster (SHEZ) study: rationale, design, and description of a prospective cohort study. Takao Y, Miyazaki Y, Onishi F, Kumihashi H, Gomi Y, Ishikawa T, Okuno Y, Mori Y, Asada H, Yamanishi K, Iso H, SHEZ Study group. J Epidemiol; 2012 Mar; 22(2):167-74. PubMed ID: 22343323 [Abstract] [Full Text] [Related]
10. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study. Sato K, Adachi K, Nakamura H, Asano K, Watanabe A, Adachi R, Kiuchi M, Kobayashi K, Matsuki T, Kaise T, Gopala K, Holl K. J Dermatol; 2017 Apr; 44(4):414-422. PubMed ID: 27917531 [Abstract] [Full Text] [Related]
11. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia. Holcomb K, Weinberg JM. J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651 [Abstract] [Full Text] [Related]
12. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Pellissier JM, Brisson M, Levin MJ. Vaccine; 2007 Nov 28; 25(49):8326-37. PubMed ID: 17980938 [Abstract] [Full Text] [Related]
13. Incidence and risk factors for herpes zoster following heart transplantation. Koo S, Gagne LS, Lee P, Pratibhu PP, James LM, Givertz MM, Marty FM. Transpl Infect Dis; 2014 Feb 28; 16(1):17-25. PubMed ID: 24147978 [Abstract] [Full Text] [Related]
14. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia. Betts RF. J Am Acad Dermatol; 2007 Dec 28; 57(6 Suppl):S143-7. PubMed ID: 18021866 [Abstract] [Full Text] [Related]
15. Predictors of herpes zoster severity and immune responses according to pain trajectories: A community-based prospective cohort study. Yamada K, Mori Y, Cui R, Kubota Y, Asada H, Okuno Y, Yamanishi K, Iso H. J Dermatol; 2023 Aug 28; 50(8):1020-1033. PubMed ID: 37208823 [Abstract] [Full Text] [Related]
16. Associations of Perceived Mental Stress, Sense of Purpose in Life, and Negative Life Events With the Risk of Incident Herpes Zoster and Postherpetic Neuralgia: The SHEZ Study. Takao Y, Okuno Y, Mori Y, Asada H, Yamanishi K, Iso H. Am J Epidemiol; 2018 Feb 01; 187(2):251-259. PubMed ID: 29036443 [Abstract] [Full Text] [Related]
17. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF. J Infect Dis; 2008 Mar 01; 197 Suppl 2():S224-7. PubMed ID: 18419401 [Abstract] [Full Text] [Related]
18. [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia]. MMW Fortschr Med; 2006 Mar 01; Spec no.1():14-5. PubMed ID: 16872127 [No Abstract] [Full Text] [Related]
19. Relationships of varicella zoster virus (VZV)-specific cell-mediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster. Park SY, Kim JY, Kwon JS, Jeon NY, Kim MC, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH. J Med Virol; 2019 Nov 01; 91(11):1995-2000. PubMed ID: 31286531 [Abstract] [Full Text] [Related]